HK1079568A1 - A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibody - Google Patents
A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibodyInfo
- Publication number
- HK1079568A1 HK1079568A1 HK05111543.4A HK05111543A HK1079568A1 HK 1079568 A1 HK1079568 A1 HK 1079568A1 HK 05111543 A HK05111543 A HK 05111543A HK 1079568 A1 HK1079568 A1 HK 1079568A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- diagnostic
- gpc3 antibody
- reagent
- diagnostic kit
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4722—Proteoglycans, e.g. aggreccan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2002/008997 WO2004023145A1 (ja) | 2002-09-04 | 2002-09-04 | Gpc3の検出による癌の診断方法 |
PCT/JP2003/011320 WO2004038420A1 (ja) | 2002-09-04 | 2003-09-04 | Gpc3の検出による癌の診断方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1079568A1 true HK1079568A1 (en) | 2006-04-07 |
Family
ID=31972304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05111543.4A HK1079568A1 (en) | 2002-09-04 | 2005-12-15 | A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibody |
Country Status (11)
Country | Link |
---|---|
US (2) | US20060014223A1 (de) |
EP (1) | EP1548442B1 (de) |
JP (1) | JP4283227B2 (de) |
KR (1) | KR101043921B1 (de) |
CN (1) | CN100554964C (de) |
AT (1) | ATE496301T1 (de) |
AU (2) | AU2002330482A1 (de) |
CA (1) | CA2497418C (de) |
DE (1) | DE60335813D1 (de) |
HK (1) | HK1079568A1 (de) |
WO (2) | WO2004023145A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022597A1 (ja) * | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3の血中可溶化n端ペプチドに対する抗体 |
PL1674111T3 (pl) * | 2004-07-09 | 2011-04-29 | Chugai Pharmaceutical Co Ltd | Przeciwciała anty-glipikan 3 |
JP4733042B2 (ja) | 2004-08-24 | 2011-07-27 | 中外製薬株式会社 | 抗グリピカン3抗体を用いたアジュバント療法 |
US20080003623A1 (en) * | 2004-10-05 | 2008-01-03 | Atsushi Nakajima | Monitoring Agent for Seriousness of Hepatitis |
CN101068836B (zh) | 2004-10-26 | 2013-08-14 | 中外制药株式会社 | 糖链改变的抗磷脂酰肌醇聚糖3抗体 |
AU2006277295B2 (en) * | 2005-08-09 | 2011-08-11 | Oncotherapy Science, Inc. | Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
US20070087005A1 (en) | 2005-10-14 | 2007-04-19 | Lazar Gregory A | Anti-glypican-3 antibody |
US7723043B2 (en) * | 2006-01-04 | 2010-05-25 | Picobella, Lp | Methods for screening for prostate cancer |
AU2008251877A1 (en) * | 2007-05-08 | 2008-11-20 | Picobella Llc | Methods for diagnosing and treating prostate and lung cancer |
SI2178921T1 (sl) | 2007-07-17 | 2016-05-31 | E.R. Squibb & Sons, L.L.C. | Monoklonska protitelesa proti glipikan-3 |
AU2008305851B2 (en) * | 2007-09-28 | 2014-12-18 | Chugai Seiyaku Kabushiki Kaisha | Anti-glypican-3 antibody having improved kinetics in plasma |
KR101105428B1 (ko) * | 2009-02-12 | 2012-01-17 | 경북대학교 산학협력단 | 글리피칸-3 단백질과 특이적으로 결합하는 펩타이드 |
CN102180969B (zh) * | 2011-01-30 | 2013-04-10 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗肝癌活性单克隆抗体及其应用 |
WO2013070468A1 (en) * | 2011-11-08 | 2013-05-16 | The Trustees Of The University Of Pennsylvania | Glypican-3-specific antibody and uses thereof |
EP3557260B1 (de) | 2012-12-21 | 2022-05-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3-gerichtetes arzneimittel, das einem patienten verabreicht wird, der auf die gpc3-gerichtete arzneimitteltherapie reagiert |
TWI693073B (zh) * | 2012-12-21 | 2020-05-11 | 日商中外製藥股份有限公司 | 對gpc3標的治療劑療法為有效之患者投與的gpc3標的治療劑 |
CN105849562B (zh) | 2013-12-24 | 2019-08-16 | 中外制药株式会社 | 可溶性gpc3蛋白质的测定方法 |
CA2936805C (en) * | 2014-01-17 | 2024-02-20 | Minomic International Ltd. | Cell surface prostate cancer antigen for diagnosis |
US11760807B2 (en) | 2014-05-08 | 2023-09-19 | Chugai Seiyaku Kabushiki Kaisha | GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy |
CN106414499A (zh) * | 2014-05-22 | 2017-02-15 | 基因泰克公司 | 抗gpc3抗体和免疫偶联物 |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
CN104829704B (zh) * | 2014-12-15 | 2016-08-17 | 河北省科学院生物研究所 | 一种磷脂酰肌醇蛋白聚糖gpc3蛋白片段及其应用和制备的杂交瘤细胞株 |
WO2017002934A1 (ja) * | 2015-07-01 | 2017-01-05 | 中外製薬株式会社 | Gpc3標的治療剤が有効である患者に投与されるgpc3標的治療剤 |
CN105759051B (zh) * | 2016-02-25 | 2018-12-18 | 广州科方生物技术股份有限公司 | 一种磷脂酰肌醇蛋白聚糖-3的定量分析试剂盒及其制备方法 |
CN108738347B (zh) * | 2016-03-10 | 2022-01-14 | 国立癌症研究中心 | 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒 |
EA201991385A1 (ru) * | 2017-01-10 | 2019-12-30 | Ямагути Юниверсити | Анти-gpc3-антитело |
CN106636108A (zh) * | 2017-01-25 | 2017-05-10 | 复旦大学附属中山医院 | 一种特异性结合gpc3的核酸适配体及其应用 |
CN107085109A (zh) * | 2017-05-15 | 2017-08-22 | 山东大学深圳研究院 | 高正电荷绿色荧光蛋白在制备肝癌早期诊断试剂盒中的应用 |
KR102154683B1 (ko) * | 2019-11-08 | 2020-09-11 | 주식회사 압타머사이언스 | 글리피칸-3 특이적 변형 압타머 및 이의 용도 |
US20240094210A1 (en) | 2021-01-18 | 2024-03-21 | Fujirebio Inc. | Method for treating soluble gpc3-containing specimen in soluble gpc3 immunoassay |
BR112023021557A2 (pt) * | 2021-04-23 | 2023-12-19 | Shanghai Henlius Biotech Inc | Anticorpos anti-gpc3 e métodos de uso |
CN117607440A (zh) * | 2023-11-28 | 2024-02-27 | 中拓生物有限公司 | 一种磷脂酰肌醇蛋白聚糖3蛋白测定试剂盒及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5644026A (en) | 1994-05-03 | 1997-07-01 | La Jolla Cancer Research Foundation | Epitaxin, a cell motility factor |
US5760000A (en) | 1994-05-13 | 1998-06-02 | University Technologies International,Inc. | Inhibition of liver cancer by the use of GnRH and GnRH analogs |
EP0773218A1 (de) | 1995-11-13 | 1997-05-14 | Mitsubishi Chemical Corporation | N-(Piperazinylalkoxyphenyl)-N'-phenylalkylharnstoffderivate als ACAT-Hemmer zur Atherosklerosebehandlung |
US5843937A (en) | 1996-05-23 | 1998-12-01 | Panorama Research, Inc. | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
TW586933B (en) | 1996-06-20 | 2004-05-11 | Chugai Pharmaceutical Co Ltd | Compositions for treating liver-complaints using EPO |
AUPO727097A0 (en) | 1997-06-10 | 1997-07-03 | Unisearch Limited | Method of treatment of hepatoma and pharmaceutical compositions for use therein |
NZ536521A (en) * | 2002-05-23 | 2006-04-28 | Sunnybrook And Womenaes Colleg | Diagnosis of hepatocellular carcinoma |
-
2002
- 2002-09-04 WO PCT/JP2002/008997 patent/WO2004023145A1/ja not_active Application Discontinuation
- 2002-09-04 AU AU2002330482A patent/AU2002330482A1/en not_active Abandoned
-
2003
- 2003-09-04 AU AU2003261943A patent/AU2003261943B2/en not_active Ceased
- 2003-09-04 US US10/526,508 patent/US20060014223A1/en not_active Abandoned
- 2003-09-04 KR KR1020057003814A patent/KR101043921B1/ko active IP Right Grant
- 2003-09-04 AT AT03809427T patent/ATE496301T1/de not_active IP Right Cessation
- 2003-09-04 JP JP2004546394A patent/JP4283227B2/ja not_active Expired - Lifetime
- 2003-09-04 WO PCT/JP2003/011320 patent/WO2004038420A1/ja active Application Filing
- 2003-09-04 CA CA2497418A patent/CA2497418C/en not_active Expired - Fee Related
- 2003-09-04 CN CNB038210770A patent/CN100554964C/zh not_active Expired - Lifetime
- 2003-09-04 EP EP03809427A patent/EP1548442B1/de not_active Expired - Lifetime
- 2003-09-04 DE DE60335813T patent/DE60335813D1/de not_active Expired - Lifetime
-
2005
- 2005-12-15 HK HK05111543.4A patent/HK1079568A1/xx not_active IP Right Cessation
-
2014
- 2014-12-22 US US14/579,474 patent/US9513292B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20150132782A1 (en) | 2015-05-14 |
AU2002330482A1 (en) | 2004-03-29 |
EP1548442B1 (de) | 2011-01-19 |
EP1548442A4 (de) | 2007-04-18 |
WO2004023145A1 (ja) | 2004-03-18 |
CA2497418A1 (en) | 2004-05-06 |
JP4283227B2 (ja) | 2009-06-24 |
AU2003261943A1 (en) | 2004-05-13 |
US9513292B2 (en) | 2016-12-06 |
US20060014223A1 (en) | 2006-01-19 |
KR20050057205A (ko) | 2005-06-16 |
DE60335813D1 (de) | 2011-03-03 |
CA2497418C (en) | 2012-02-07 |
KR101043921B1 (ko) | 2011-06-29 |
CN100554964C (zh) | 2009-10-28 |
WO2004038420A1 (ja) | 2004-05-06 |
CN1678911A (zh) | 2005-10-05 |
ATE496301T1 (de) | 2011-02-15 |
AU2003261943B2 (en) | 2009-07-23 |
JPWO2004038420A1 (ja) | 2006-02-23 |
EP1548442A1 (de) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079568A1 (en) | A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibody | |
CN201072416Y (zh) | 化验装置 | |
AU2003224447A1 (en) | Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples | |
HK1084183A1 (en) | Diagnostic test for analytes in a sample | |
WO2006089027A3 (en) | Lateral flow test kit and method for detecting an analyte | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
AU2003230254A1 (en) | Method of diagnosis of foot and mouth disease and the diagnostic kit | |
PL368690A1 (en) | Method for detecting analyte(s) using magnetic colloidal particles | |
WO2002035232A3 (en) | Method for detecting ovarian cancer based on human kallikrein 6 (hk6) | |
ATE395812T1 (de) | Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests | |
WO2003016907A1 (fr) | Reactif de dosage pour antigene de la laminine 5 dans un echantillon biologique et procede de dosage | |
EP1605263A3 (de) | Verfahren, Zusammensetzung und Satz zur Messung der Zelloberflächen-Expression | |
AU2003260457A1 (en) | A method and kit for the quantitative and/or qualitative detection of components in a sample | |
IL67020A0 (en) | Immunoassay method,reagent means and test kit for determining an iodothyronine in a biological fluid | |
PT918991E (pt) | Metodo de ensaio | |
DE60333876D1 (de) | Methoden zum Nachweis Analyten in Proben | |
EP1214447B8 (de) | Nachweis des pyruvatkinase-isoenzyms im stuhl | |
WO2003076896A3 (en) | Use of biomarkers to detect breast cancer | |
DE602004015953D1 (de) | Festphase immunochromatographische testverfahren | |
EP1275963A3 (de) | Volumenzähler-Prüfvorrichtung | |
WO2002077645A3 (en) | Method for the measurement of soluble analytes | |
CA2366651A1 (en) | A method for detecting megsin protein and use thereof | |
AU1690899A (en) | Method for testing crohn's disease and testing kit therefor | |
WO2005031365A3 (en) | Rapid determination of hepatocyte growth factor (hgf) in the body fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170904 |